33rd Annual Meeting of the Society for Immunotherapy of Cancer (SITC) held from November 7 to 11, 2018
Title: Preclinical characterization of IL-2 Superkines engineered with biased CD8+ T cell stimulating properties
Poster #: P415
Date/Time: Friday, November 9th 2018 from 12:45 pm to 6:30 pm EST
Location: Hall E, Walter E. Washington Convention Center in Washington, D.C.
For more investor information, Please contact:
Elizabeth Williams, Chief Financial Officer